Preventice Solutions announced today that it appointed former Medtronic executive Tom Sheehy as its new executive vice president and chief commercial officer, effective immediately. Sheehy previously served as a senior area sales director for the diagnostics and coronary sales team at medtech giant Medtronic (NYSE:MDT). He also held a national sales leadership role, integrating TYRX antibiotic […]
HRS 2019 Roundup: Medtronic touts extravascular ICD pilot
The pilot study of an extravascular implantable cardiac defibrillator developed by Medtronic (NYSE:MDT), which is designed to deliver both defibrillation and anti-tachycardia pacing using leads placed outside the heart and venous system, showed strong safety and efficacy results. The safety outcome for the 26-patient study, presented last week at the annual meeting of the Heart […]
HRS 2018 Roundup: Device-related blood clots with Boston Scientific’s Watchman implant
Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman […]
Boston Scientific inks deal with Preventice
Boston Scientific (NYSE:BSX) said yesterday it inked a sales and marketing deal with cardio-focused remote patient care company Preventice Solutions. The new deal will position medical device giant Boston Scientific as Preventice’s exclusive sales and marketing representative for its cardiology-related diagnostic and monitoring offerings, the companies said. “This agreement marks an important strategic milestone for Preventice Solutions. […]
Second suitor cedes the field early to Zimmer | The week in medtech M&A
Remote monitoring companies join forces for cardiac patients
Remote patient care company Preventice and remote cardiac monitoring devices maker eCardio Diagnostics announced this week that they would join forces and merge sales operations under a new holding company, Preventice Inc.
The new company combines Preventice’s commercially available wireless remote cardiac monitoring systems with eCardio’s national sales force and patient monitoring center.
FDA news: Covidien, Preventice, Precision Spine win FDA clearances
A trio of medical device companies won nods from the FDA’s Center for Devices & Radiological Health this week, including a surgical sealer, a wireless cardiac monitor and a spinal plating system
Covidien (NYSE:COV) said it won 510(k) clearance from the FDA for its LigaSure surgical sealer/divider for ear, nose and throat procedures.
